SYHA1815

SYHA1815 · Shanghai Runshi Pharmaceutical Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYHA1815, covering 2021-11-03 to 2021-11-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

See pricing